Therefore, regarding the treatment of osteosarcoma patients, the expression of PARP1 might be helpful in the estimation of prognosis and potentially the selection of osteosarcoma patients for anti-PARP therapy. This evidence concerns the gene PARP1 and osteosarcoma.